OP0069 SEQUENTIAL B CELL/T CELL THERAPY TO RE-INDUCE HUMORAL IMMUNE TOLERANCE IN ACPA-POSITIVE RHEUMATOID ARTHRITIS (TOLERA): FIRST RESULTS FROM PHASE 2, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL COMPARING RITUXIMAB AND ABATACEPT WITH RITUXIMAB ALONEA. Kleyer, Gerhard Krönke, Seda BAYAT et al.|Annals of the Rheumatic Diseases|2024Cited by 0